Association of IL-10 to coronary disease severity in patients with metabolic syndrome
ConclusionsHigher IL-10 levels in patients with MetS are associated with lower incidence of severe CAD, suggesting a protective effect through its anti-inflammatory activity even in the presence of higher levels of pro-inflammatory cytokines.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Heart | Heart Attack | Heart Disease | Laboratory Medicine | Metabolic Syndrome | Study